Florida’s dengue surge is no longer a travel-only problem
Florida physicians are being forced to rethink a familiar tropical diagnosis. dengue now belongs in the differential diagnosis for feverish patients who have never left the state, especially in counties where local transmission has taken hold and mosquito surveillance has already identified infected pools of Aedes aegypti.
State data show 425 locally acquired cases this year across 11 counties, with 57 additional cases reported in the week of Oct. 11-17. Hillsborough County alone accounts for 346 cases, about 81% of the state total. The scale is large enough to alter bedside reasoning: a negative travel history no longer closes the door on dengue in parts of Florida, and waiting for classic epidemiologic clues can delay the diagnosis when the patient is already in the phase where complications begin to emerge.
One local death has already been confirmed this year in Hillsborough County.
The outbreak pattern points to sustained local transmission
The case curve climbed sharply through the late summer and early fall, with symptom onset reported for 21 cases in July, 160 in August, 226 in September, and 18 so far in October through the latest state reporting window. Of 395 locally acquired cases typed by polymerase chain reaction, 393 were dengue virus serotype 2 and two were serotype 3. In parallel, public health workers identified DENV-2 in 20 mosquito pools, including 19 in Hillsborough County and one in Pasco County.
That virologic pattern matters clinically. A dominant serotype in a defined geographic cluster signals active transmission chains rather than isolated imported infections, and it raises the likelihood that the next febrile patient presenting to urgent care, primary care, or the emergency department may be part of the same cycle. The outbreak has also spread beyond Tampa Bay: Pinellas County has 51 local cases, while Miami-Dade, Orange, Pasco, Citrus, Brevard, Broward, Manatee, Palm Beach, Polk, and Seminole counties have all recorded locally acquired infections.
Hillsborough County declared a state of local emergency in late September to speed mosquito-control spending, and Pinellas County extended its declaration as well. Eight counties were under mosquito-borne illness alert and 10 more under advisory as of the state report cutoff. Local public health measures are trying to slow the vector, but the clinical burden has already reached practice settings.
Fever workups now need dengue in the room
The first bedside question has changed. Travel history still helps, but it can no longer be the gatekeeper in Florida.
The CDC advises clinicians to consider dengue in any patient with fever who lives in or recently traveled to an area with risk. Common symptoms include severe headache, pain behind the eyes, muscle and joint pain, and rash. Florida health officials warn that dengue is often mistaken for influenza or another viral syndrome, which is precisely how missed cases enter outpatient care: the patient looks like a routine febrile illness until the laboratory pattern or warning signs force a rethink.
Testing hinges on timing. During the first seven days of illness, the preferred approach is nucleic acid amplification testing such as reverse transcription PCR plus an IgM antibody test. An NS1 antigen test plus IgM is the alternative. After day seven, IgM becomes the primary test. A negative NAAT or NS1 result does not exclude infection, so a single negative early test should not end clinical suspicion when the syndrome and geography fit.
Serum is the preferred sample, and both state health departments and commercial laboratories can perform testing. Because the same mosquitoes can spread chikungunya, clinicians also need to keep that infection in view. Florida has already logged 88 travel-associated chikungunya cases and one locally acquired case this year.
Warning signs mark the turn toward severe dengue
Dengue can deteriorate quickly after the initial febrile phase. The critical period usually falls three to eight days after fever begins, when patients may appear to improve just as plasma leakage, bleeding risk, or hemodynamic instability starts to unfold.
Severe abdominal pain or tenderness, persistent vomiting, pleural effusion or ascites, mucosal bleeding, altered mental status, liver enlargement of at least 2 centimeters, and a progressive rise in hematocrit are the warning signs that require constant reassessment. These findings are not optional footnotes in the chart; they are the clinical markers that separate uncomplicated disease from the patient who may need admission before shock or major hemorrhage develops.
Hospital management is recommended for patients with warning signs. Outpatient care is appropriate only for patients without warning signs who remain hemodynamically stable and can tolerate oral fluids. The CDC recommends acetaminophen for fever, avoidance of aspirin and nonsteroidal anti-inflammatory drugs, generous oral hydration, regular follow-up, ideally daily, and complete blood counts as indicated.
A rising hematocrit in the wrong clinical context can signal hemoconcentration from capillary leak, not simple dehydration.
Reporting and follow-through now carry public health weight
In a sustained outbreak, diagnosis is not only about individual care. Confirmed cases inform surveillance maps, mosquito-control deployment, travel counseling, and alerts to neighboring counties where transmission can take hold once infected travelers reintroduce the virus into a receptive vector population.
That is the practical consequence for front-line clinicians: every suspected case has value beyond the individual encounter. Prompt testing, appropriate reporting, and early counseling on mosquito avoidance can help interrupt further transmission. In Florida, where travel-associated cases continue to seed the virus and local transmission is already established, the next febrile patient may be the first recognized case in a new neighborhood cluster rather than an isolated import.
The state’s 2026 outbreak has already exceeded the number of locally acquired cases reported in 2025 and far surpassed Florida’s previous modern high. For clinicians, the immediate task is narrower and more concrete: identify dengue early, monitor for warning signs, and avoid medications that can worsen bleeding while the illness is still unfolding.